TWD 33.1
(-3.22%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 104.35 Million TWD | -3.03% |
2022 | 55.21 Million TWD | 7.89% |
2021 | 51.17 Million TWD | -2.96% |
2020 | 52.73 Million TWD | -4.04% |
2019 | 54.95 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 13.68 Million TWD | 115.93% |
2024 Q1 | 13.36 Million TWD | -1.47% |
2023 Q4 | 13.56 Million TWD | 2.0% |
2023 FY | 53.54 Million TWD | -3.03% |
2023 Q3 | 13.29 Million TWD | -5.84% |
2023 Q2 | 14.12 Million TWD | 12.47% |
2023 Q1 | 12.55 Million TWD | -12.45% |
2022 FY | 55.21 Million TWD | 7.89% |
2022 Q4 | 14.34 Million TWD | 0.0% |
2021 FY | 51.17 Million TWD | -2.96% |
2020 FY | 52.73 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -31617.629% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 18.265% |
Level Biotechnology Inc. | 151.99 Million TWD | 31.345% |
Sagittarius Life Science Corp | 135.85 Million TWD | 23.188% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -37.559% |
TaiMed Biologics Inc. | 225.23 Million TWD | 53.67% |
GlycoNex Incorporation | 995 Thousand TWD | -10387.538% |
VBI | 32.55 Million TWD | -220.538% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 59.376% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 46.262% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -126.737% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 12.976% |
Visgeneer Inc. | 67.48 Million TWD | -54.635% |
Mycenax Biotech Inc. | -375.19 Million TWD | 127.813% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 79.543% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -63.296% |
Neith Corporation | 66.87 Million TWD | -56.044% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 92.774% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -255.516% |
Enimmune corporation | 220.1 Million TWD | 52.59% |
TaiRx, Inc. | 217.13 Million TWD | 51.942% |
CHO Pharma, Inc. | 268.99 Million TWD | 61.208% |
EirGenix Inc. | 236.74 Million TWD | 55.922% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 70.821% |
Lin BioScience, Inc. | 1.09 Billion TWD | 90.486% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 60.794% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -110.934% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -9535.365% |
Lukas Biomedical Inc. | 177.45 Million TWD | 41.194% |
RBC Bioscience Corporation | 58.35 Million TWD | -78.818% |
BiOptic Inc. | 108.69 Million TWD | 3.994% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -115845.556% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -50.47% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -3890.478% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 83.794% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -11.801% |
NaviFUS Corp. | 11.82 Million TWD | -782.312% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 45.288% |
Sinew Pharma Inc. | 186.25 Million TWD | 43.974% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -40.971% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 52.653% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -151.563% |
AP Biosciences Inc | 32.25 Million TWD | -223.539% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 94.361% |
3D Global Biotech Inc. | 5.27 Million TWD | -1878.593% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 67.115% |
Intech Biopharm Corporation | -163.99 Million TWD | 163.631% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 90.759% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -151.557% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 38.456% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 29.024% |
TCI GENE Inc. | 174.61 Million TWD | 40.24% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -579627.778% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 65.325% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 64.135% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -24.309% |
PharmaEngine, Inc. | 441.78 Million TWD | 76.38% |
Savior Lifetec Corporation | 223.36 Million TWD | 53.283% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 59.676% |
OBI Pharma, Inc. | 2.01 Billion TWD | 94.825% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 24.857% |
Acepodia, Inc. | 452.56 Million TWD | 76.942% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 80.709% |